Trish Dauphin
Family · New Orleans, LANPI 1740831916
Payments from drug & device makers
Across 84 payments — averaging $41.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$697
- Viiv Healthcare Company$366
- Sanofi$246
- Alkermes, Inc.$230
- Boston Scientific$167
- Dexcom, Inc.$163
- plus $2K from 20 others
What the payments were for
- Food & beverage$3,489100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 27 | $697 |
| Viiv Healthcare Company | 8 | $366 |
| Sanofi | 2 | $246 |
| Alkermes, Inc. | 6 | $230 |
| Boston Scientific | 2 | $167 |
| Dexcom, Inc. | 1 | $163 |
| Exact Sciences | 4 | $151 |
| Hologic Sales And Service, LLC | 1 | $134 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Edwards Lifesciences | 1 | $125 |
| Lilly USA, LLC | 1 | $123 |
| Scilex Pharmaceuticals Inc. | 6 | $121 |
| AstraZeneca | 1 | $114 |
| Agile Therapeutics, Inc. | 2 | $111 |
| AbbVie | 1 | $101 |
| Jazz Pharmaceuticals Inc. | 1 | $97 |
| Johnson & Johnson(2 entities) | 3 | $89 |
| Merck | 5 | $80 |
| Braeburn Inc. | 2 | $44 |
| Theratechnologies Inc. | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Neurocrine Biosciences, Inc. | 1 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $28 |
| Novartis | 1 | $28 |
| EMD Serono, Inc. | 1 | $22 |
| Corium, LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FABRAZYME$246
- DEXCOM G7 GSS (161)$163
- DEXCOM STELO GLUCOSE BIOSENSOR$163
- WaveWriter Alpha Prime 16$140
- Aptima$134
- AJOVY$125
- Epclusa$125
- Yeztugo$125
- VIVITROL$125
- CABENUVA$123
- MOUNJARO$123
- DOVATO$121
- The Cologuard Plus Collection Kit$115
- VRAYLAR$101
How this compares
$3,489 in reported general payments places this provider in the 85th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 41 | $28,430 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 89 | $15,514 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $418 |
| Gabapentin | 27 | $191 |
| Atorvastatin Calcium | 23 | $105 |
| Omeprazole | 20 | $92 |
| Quetiapine Fumarate | 12 | $84 |
| Losartan Potassium | 15 | $71 |
| Amlodipine Besylate | 35 | $67 |
| Levothyroxine Sodium | 11 | $63 |
| Trazodone Hcl | 14 | $45 |
| Hydrochlorothiazide | 18 | $15 |
Paid to pharmacies, not to this prescriber.
Other family in New Orleans
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Robert ByramNew Orleans$49K
- Amy SchmittNew Orleans$48K
- Eric BabineauxNew Orleans$32K
- Cherie AlbroNew Orleans$29K
- Aimee ScroggsNew Orleans$20K
- Kelly BaquetNew Orleans$18K
- Lori LemoineNew Orleans$17K
- Jennifer GreenheckNew Orleans$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.